EUVIMEDEUVIMED entdecken
Crossref

Rapid and validated LC–APCI–MS/MS method for determination of N-nitroso vonoprazan in pharmaceutical products

Filiz Demir iD, Sıdıka Ertürk Toker

Journal of Chromatographic Science · 2026

DOI: 10.1093/chromsci/bmag024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Chromatographic Science, 2026. Verfasst von Filiz Demir und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Analytical Chemistry, Graduate School of Health Sciences, Istanbul University, Bozdoğan Kemeri Street No. 4, Vezneciler, Fatih, 34116 I…. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Pyrroles, Liquid Chromatography-Mass Spectrometry, Sulfonamides. Die Arbeit nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The primary objective of this study was to develop and validate a liquid chromatography–atmospheric pressure chemical ionization–tandem mass spectrometric (LC–APCI–MS/MS) method for the determination of trace levels of N-nitroso vonoprazan (NVNP) in vonoprazan active pharmaceutical ingredient (API) and pharmaceutical products. Chromatographic separation was achieved on an Acquity® Premier HSS T3 column under isocratic conditions using 0.1% formic acid in water and acetonitrile as the mobile phase. Detection was performed in positive ion mode using multiple reaction monitoring. The method was validated according to ICH Q2(R2) guidelines for selectivity, linearity, accuracy, precision, robustness, matrix effect, limit of detection (LOD), and limit of quantification (LOQ). The method was linear over the concentration range of 0.24–50.0 ng/mL (R2 = 0.9971), with recoveries of 85.6%–99.2% and relative standard deviation values below 6.1%. The validated LOD and LOQ were 0.10 and 0.24 ng/mL, respectively; the latter corresponds to 0.24 μg/g (240 ppb) in the pharmaceutical product. Matrix effect evaluation showed 91.6% response (8.4% ion suppression), indicating minimal matrix interference. The validated LC–APCI–MS/MS method was successfully applied to both API and finished products and is suitable for routine quality control, stability studies, nitrosamine risk assessment, and regulatory monitoring of NVNP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryPyrrolesLiquid Chromatography-Mass SpectrometrySulfonamidesReproducibility of ResultsLimit of DetectionLinear ModelsChromatography, Liquid

Substanzen

PyrrolesSulfonamidesvonoprazan

Autor:innen und Institutionen

  • Department of Analytical Chemistry, Graduate School of Health Sciences, Istanbul University, Bozdoğan Kemeri Street No. 4, Vezneciler, Fatih, 34116 Istanbul, Türkiye.
  • Department of Analytical Chemistry, Faculty of Pharmacy, Istanbul University, Besim Ömer Paşa Street No. 1, Fatih, 34116 Istanbul, Türkiye.

ORCID-Profile: Filiz Demir

Zitieren

APA

Demir, F., & Toker, S. E. (2026). Rapid and validated LC–APCI–MS/MS method for determination of N-nitroso vonoprazan in pharmaceutical products. Journal of Chromatographic Science. https://doi.org/10.1093/chromsci/bmag024

Vancouver

Demir F, Toker SE. Rapid and validated LC–APCI–MS/MS method for determination of N-nitroso vonoprazan in pharmaceutical products. Journal of Chromatographic Science. 2026. doi:10.1093/chromsci/bmag024

BibTeX
@article{Demir2026,
  author = {Demir, Filiz and Toker, Sıdıka Ertürk},
  title = {Rapid and validated LC–APCI–MS/MS method for determination of N-nitroso vonoprazan in pharmaceutical products},
  journal = {Journal of Chromatographic Science},
  year = {2026},
  doi = {10.1093/chromsci/bmag024}
}
Kostenlos starten →